REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/25/2026
Back to search
Official data from USPTO
REVERSE TRANSLATIONAL MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REVERSE TRANSLATIONAL MEDICINE
ST13
US500000085984179Class
5, 42, 44
Filing
85984179
Registration
5188931
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
102
Latest update
04/26/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
06/20/2012
Registration date
04/25/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2023
Last transaction
04/26/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Schlieren, CH
Examiner
LEHKER, DAWN FELDMAN
Law office
M20
Holders and representatives
Holders
Neurimmune Holding AG
Representatives
Janice Housey
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; synthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; biological preparations for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; diagnostic preparations for medical and veterinary use; Dietetic foodgluten-free foodlow-sodium foodlow-calorie or reduced calorie food for weight reduction adapted for medical purposesdietetic bread and dietetic noodles; dietetic beveragesgluten-free beverageslow-sodium beveragesdietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposeslow calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases
Class 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs; Consultation and providing information about testinginspection or research of pharmaceuticalscosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testinginspection or research of medical treatment and technique; scientific research about health care; biology research ; computer hardware design and development; computer software design and development
Class 44
Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
102 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/15/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/15/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2023
E815
TEAS SECTION 8 & 15 RECEIVED
12/15/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/21/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/25/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
03/17/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
12/01/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2016
PUBO
PUBLISHED FOR OPPOSITION
11/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2016
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/28/2016
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
08/04/2016
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
08/04/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
07/13/2016
APET
ASSIGNED TO PETITION STAFF
07/08/2016
DRRR
DIVISIONAL REQUEST RECEIVED
06/22/2016
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/22/2016
UNTD
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
06/10/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/07/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/26/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/23/2016
EX4G
SOU EXTENSION 4 GRANTED
04/22/2016
EXT4
SOU EXTENSION 4 FILED
04/21/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/21/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/16/2015
EX3G
SOU EXTENSION 3 GRANTED
10/15/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/14/2015
EXT3
SOU EXTENSION 3 FILED
10/07/2015
EEXT
SOU TEAS EXTENSION RECEIVED
10/07/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/19/2015
EX2G
SOU EXTENSION 2 GRANTED
05/16/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/16/2015
EXT2
SOU EXTENSION 2 FILED
04/15/2015
EEXT
SOU TEAS EXTENSION RECEIVED
04/15/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/17/2014
EX1G
SOU EXTENSION 1 GRANTED
06/13/2014
EXT1
SOU EXTENSION 1 FILED
06/13/2014
EEXT
SOU TEAS EXTENSION RECEIVED
06/13/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/06/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2014
PUBO
PUBLISHED FOR OPPOSITION
03/11/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/06/2014
ALIE
ASSIGNED TO LIE
02/05/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
02/05/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/05/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
02/05/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/05/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/04/2013
GNRT
NON-FINAL ACTION E-MAILED
11/04/2013
CNRT
NON-FINAL ACTION WRITTEN
11/04/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/25/2013
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/20/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/07/2013
ALIE
ASSIGNED TO LIE
09/28/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/16/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/16/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2013
GNRT
NON-FINAL ACTION E-MAILED
03/22/2013
CNRT
NON-FINAL ACTION WRITTEN
03/22/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2012
GNRT
NON-FINAL ACTION E-MAILED
10/16/2012
CNRT
NON-FINAL ACTION WRITTEN
10/16/2012
DOCK
ASSIGNED TO EXAMINER
10/05/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2012
NWAP
NEW APPLICATION ENTERED
06/23/2012
Continuous trademark protection
Get notified about every new filing that threatens REVERSE TRANSLATIONAL MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.